15250-m-cuypers

53 HRQoL changes prior to Pca treatment onset 3 Table 1. Demographics t0 - No cancer (N=254) t0 - Pca (N=123) t1 - Pca (N=80) Age at inclusion ≤ 65 years 106 (44%) 40 (33%) 24 (30%) 66-75 years 115 (48%) 73 (60%) 50 (63%) ≥ 76 years 20 (8%) 9 (7%) 5 (6%) Education Low 109 (43%) 48 (39%) 31 (39%) Medium 60 (24%) 37 (30%) 25 (31%) High 78 (31%) 36 (29%) 23 (29%) Other/not specified 4 (2%) 2 (2%) 1 (1%) Current occupation Employed 70 (28%) 28 (23%) 15 (19%) Not employed 183 (72%) 93 (77%) 64 (81%) Partnership Partner 224 (89%) 115 (94%) 74 (95%) No partner 28 (11%) 7 (6%) 5 (6%) Children Yes 228 (91%) 118 (96%) 77 (96%) No 24 (9%) 5 (4%) 3 (4%) Prostate Specific Antigen (PSA) ≤ 5 ng/ml 42 (17%) 19 (16%) 19 (25%) 5.01-10 ng/ml 125 (49%) 59 (48%) 37 (49%) ≥ 10.01 ng/ml 85 (34%) 44 (36%) 20 (26%) Selected treatment Active surveillance 26 (34%) Radical prostatectomy 22 (29%) Radiotherapy 28 (37%) Numbers do not always add up to the same total due to item non-response Differences between groups did not reach statistical significance